R&D

MiNA Therapeutics Chief Scientific Officer to speak at RNA Therapeutics Conference 2019

https://pharmaphorum.com/partner-content/mina-therapeutics-chief-scientific-officer-to-speak-at-rna-therapeutics-conference-2019/

Roche’s SMA drug gets PRIME regulatory status in Europe

https://pharmaphorum.com/news/roches-sma-drug-gets-prime-regulatory-status-in-europe/

BMS looks to RNA splicing to boost immunotherapies

https://pharmaphorum.com/news/bms-looks-to-rna-splicing-to-boost-immunotherapies/

ConvaTec looks to support UK wound care through sector deal

https://pharmaphorum.com/news/convatec-support-uk-wound-care-sector-deal/

Lilly focuses on tau with AC Immune Alzheimer’s R&D tie-up

https://pharmaphorum.com/news/lilly-focuses-on-tau-with-ac-immune-alzheimers-rd-tie-up/

CarThera raises €9m to tackle the blood-brain barrier

https://pharmaphorum.com/news/carthera-raises-e9m-to-tackle-the-blood-brain-barrier/

Genentech develop Antibiotic with potential to lead to new class of Antibiotics

https://pharmaphorum.com/partner-content/genentech-develop-antibiotic-with-potential-to-lead-to-new-class-of-antibiotics/

WuXi AppTec eyes acquisitions after $1bn Hong Kong IPO

https://pharmaphorum.com/news/wuxi-apptec-eyes-acquisitions-after-1bn-hong-kong-ipo/

Neurocrine slumps as Tourette’s drug fails clinical trial

https://pharmaphorum.com/news/neurocrine-slumps-as-tourettes-drug-fails-clinical-trial/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search